Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets

Out-
      side
 



 
 MRI Database 
SEARCH FOR    
  2 3 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
previous     61 - 65 (of 77)     next 
DA-Da   Da-De   De-De   De-De   De-De   De-Di   Di-Di   Di-Di   Di-Di   Di-Do   Do-Do   Do-Dr   Dr-Du     Du-Du   Dw-Dy   Dy-Dy   
MRI Resources 
Claustrophobia - Spectroscopy pool - Open Directory Project - Breast MRI - Devices - MRA
 
Driven Equilibrium Magnetization PreparationInfoSheet: - Sequences -
Intro, Overview, 
Types of, 
etc.
 
(DE prep) See Driven Equilibrium.
spacer
Dropout
 
When the received signal is not digitized.
spacer

• View the DATABASE results for 'Dropout' (3).Open this link in a new window

MRI Resources 
Spectroscopy pool - Spectroscopy - Hospitals - MRI Technician and Technologist Career - Open Directory Project - Distributors
 
Drug Development and Approval Process (USA)
 
Different stages of the drug development and approval process in the USA, lead from preclinical trials (testing in animals), first application in humans through limited and broad clinical tests, to postmarketing studies.
Drug Development and Approval Process (USA)
By Dale E. Wierenga, Ph.D. and C. Robert Eaton
Office of Research and Development
Pharmaceutical Manufacturers Association

'In reviewing this report, it is important to keep in mind the realities of the drug discovery and development process. The U.S. system of new drug approvals is perhaps the most rigorous in the world. On average, it costs a company $359 million to get one new medicine from the laboratory to the pharmacist's shelf, according to a February 1993 report by the Congressional Office of Technology Assessment.'

See also Phase 1 2 3 4 Drug Trials, Food and Drug Administration, and European Medicines Agency.
spacer
DTPAInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.
 
The diethylenetriaminepentaacetic acid-chelate contains five acetate moieties linked by a molecular backbone, which bind a metallic ion complex. This chemical bonding solves the problem of toxicity of, e.g. Gadolinium, because DTPA complexes are very stable.
DTPA is used together with technetium-99m as a nuclear imaging radiopharmaceutical and with gadolinium as a MR contrast medium. DTPA chelates undergo renal glomerular filtration and can be used to quantify it. DTPA is also used as a decontamination agent in individuals who have ingested radioactive materials.
spacer

• View the NEWS results for 'DTPA' (5).Open this link in a new window.

• View the DATABASE results for 'DTPA' (42).Open this link in a new window

 
Further Reading:
  Basics:
Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues
   by radiology.rsnajnls.org    
  News & More:
MRI Contrast Agent Analysis from Bruker
Sunday, 11 August 2013   by www.azom.com    
Dual Echo Fast Acquisition Interleaved Spin EchoInfoSheet: - Sequences -
Intro, Overview, 
Types of, 
etc.
 
(DEFAISE) Simultaneously acquired T2 and density weighted echoes in a FSE sequence.

See Fast Spin Echo.
spacer
 
Further Reading:
  Basics:
BASIC PRINCIPLES OF MR IMAGING
   by spinwarp.ucsd.edu    
MRI Resources 
Fluorescence - Safety Products - Libraries - General - Calculation - Online Books
 
previous       61 - 65 (of 77)      next 
DA-Da   Da-De   De-De   De-De   De-De   De-Di   Di-Di   Di-Di   Di-Di   Di-Do   Do-Do   Do-Dr    Dr-Du    Du-Du   Dw-Dy   Dy-Dy   
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



New acceleration techniques will :
reduce scan times 
cause artifacts 
increase expenses 
be useful if you have a lot of experience 
doesn't do much 
never heard of 

Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 29 March 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]